Point Of Care (POC) Immunoassay Analyzer Expansion Market Analysis: Understanding The Drivers Behind 8.8% CAGR Through 2030 Growth
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Point Of Care (POC) Immunoassay Analyzer Expansion Market Size And Revenue Outlook Through 2030
The point of care (POC) immunoassay analyzer expansion market has demonstrated significant growth in recent years. This market is projected to expand from $4.9 billion in 2025 to $5.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. The historical expansion of this market can be attributed to the rising prevalence of infectious diseases, the development of hospital laboratory infrastructure, an increasing demand for rapid diagnostics, the wider adoption of immunoassay technology, and enhancements in antibody and antigen detection methods.
The point of care (POC) immunoassay analyzer expansion market size is projected to experience substantial growth in the coming years. It is anticipated to reach $7.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. The growth during the forecast period can be attributed to the broadening of personalized medicine and biomarker-based testing, an increasing shift toward decentralized healthcare delivery, the rising adoption of AI-enabled diagnostic systems, the expansion of home-based healthcare monitoring, and a rise in regulatory approvals for rapid diagnostic devices. Major trends anticipated in the forecast period include the expansion of decentralized point-of-care diagnostic ecosystems, the increasing adoption of multiplex immunoassay platforms, the integration of wireless connectivity into portable analyzers, the development of cartridge-based rapid testing systems, and the growing demand for at-home immunodiagnostic solutions.
Get A Free Sample Report With In-Depth Market Insights:
Point Of Care (POC) Immunoassay Analyzer Expansion Market Growth Factors: What’s Supporting Expansion?
The increasing occurrence of infectious diseases is projected to fuel the expansion of the point of care immunoassay analyser expansion market in the future. These conditions are caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which are transmitted directly or indirectly among individuals. The rise in infectious disease prevalence stems from higher global population density, which heightens the likelihood of transmission and disease dissemination. Point of care (POC) immunoassay analyzers expansion aids in addressing infectious diseases by allowing swift, precise, and decentralized identification of infectious biomarkers, thereby enhancing early detection and management initiatives. As an illustration, in March 2025, the UK Health Security Agency, a UK-based government health authority, reported a 13% rise in tuberculosis cases in england during 2024, reaching 5,480 cases compared to 4,850 cases in 2023. Consequently, the increasing occurrence of infectious diseases is boosting the expansion of the point of care immunoassay analyzer expansion market.
Point Of Care (POC) Immunoassay Analyzer Expansion Market Segmentation And Category Overview
The point of care (poc) immunoassay analyzer expansion market covered in this report is segmented –
1) By Product Type: Portable Analyzers, Benchtop Analyzers, Microfluidic Analyzers
2) By Technology: Chemiluminescence, Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay
3) By Sample Type: Blood, Urine, Saliva
4) By Application: Infectious Diseases, Hormonal Testing, Autoimmune Disorders, Cardiac Markers, Oncology
5) By End User: Hospitals, Diagnostic Laboratories, Home Care Settings, Academic Research Institutions
Subsegments:
1) By Portable Analyzers: Handheld Immunoassay Analyzers, Battery Operated Diagnostic Analyzers, Wireless Connected Portable Analyzers, Single Test Portable Analyzers, Multi Test Portable Analyzers
2) By Benchtop Analyzers: Compact Laboratory Benchtop Analyzers, High Throughput Benchtop Analyzers, Fully Automated Benchtop Analyzers, Semi Automated Benchtop Analyzers, Multi Assay Benchtop Systems
3) By Microfluidic Analyzers: Lab On A Chip Analyzers, Cartridge Based Microfluidic Analyzers, Continuous Flow Microfluidic Systems, Droplet Based Microfluidic Analyzers, Integrated Microfluidic Diagnostic Systems
Point Of Care (POC) Immunoassay Analyzer Expansion Market Industry Trends: What’s Reshaping Demand?
Leading companies in the point of care immunoassay analyser expansion market are prioritizing the development of innovative solutions, such as advancements in immunoassay technologies, to meet the increasing demand for rapid diagnostics, decentralized healthcare, and real-time clinical decision-making in emergency and remote environments. These sophisticated immunoassay analyzers are compact diagnostic platforms that leverage antigen–antibody reactions for highly sensitive biomarker detection, offering features like quick turnaround times, portability, minimal sample preparation, and multiplex testing capabilities. Unlike traditional centralized laboratory analyzers that necessitate complex infrastructure and longer processing, POC systems enable near-patient testing, providing faster results and improved accessibility. For example, in July 2023, Anbio Biotechnology, a China-based diagnostics company, introduced the AF-100S Fluorescence Immunoassay Analyzer. This system functions as a compact, automated fluorescent immunoassay analyzer designed for the rapid quantitative detection of biomarkers in clinical samples such as whole blood, serum, and plasma. It integrates fluorescence-based detection technology with automated calibration and built-in quality control, ensuring high sensitivity and accuracy comparable to centralized laboratory systems. Additionally, the analyzer offers a user-friendly interface and delivers test results within minutes, making it highly appropriate for emergency departments, clinics, and decentralized healthcare settings.
Point Of Care (POC) Immunoassay Analyzer Expansion Market Company Landscape And Competitive Strategy
Major companies operating in the point of care (poc) immunoassay analyzer expansion market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Becton, Dickinson and Company (BD), Beckman Coulter, Bruker Corporation, BioRad Laboratories, Qiagen N. V., Diasorin, Lepu Medical Technology, SD Biosensor, Eiken Chemical Co. Ltd., Molbio Diagnostics Pvt. Ltd., Maccura Biotechnology Co. Ltd., QuantuMDx Group Ltd., Ustar Biotechnologies Ltd., Mylab Discovery Solutions Pvt Ltd., Akonni Biosystems Inc., Zeesan Biotech Co. Ltd.
View The Full Point Of Care (POC) Immunoassay Analyzer Expansion Market Report:
Point Of Care (POC) Immunoassay Analyzer Expansion Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the point-of-care immunoassay analyzer expansion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care (POC) immunoassay analyzer expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
